Market Place
Sourcing Support
Ovid Therapeutics Reports Q2 2024 Results And Business Updates
13 Aug 2024 //
GLOBENEWSWIRE
Takeda Announces Phase 3 Results For Soticlestat In Lennox-Gastaut Syndrome
17 Jun 2024 //
BUSINESSWIRE
Ovid Reports On Takeda’s Phase 3 Topline Results For Soticlestat
17 Jun 2024 //
GLOBENEWSWIRE
Epilepsy fail hands late-stage pipeline blow to Takeda
17 Jun 2024 //
PHARMAPHORUM
Takeda takes full control of drug for rare epilepsies
04 Mar 2021 //
BIOPAHRAMADIVE
Takeda, Ovid Therapeutics announce phase 2 ELEKTRA study of soticlestat
27 Aug 2020 //
PHARMABIZ
New data lead Ovid, Takeda to push seizure drug into final testing
27 Aug 2020 //
BIOPHARMADIVE
New data lead Ovid, Takeda to push seizure drug into final testing
25 Aug 2020 //
BIOPHARMADIVE
Phase 2 ELEKTRA Study of Soticlestat (TAK-935/OV935) Meets Primary Endpoint
25 Aug 2020 //
PRESS RELEASE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.